New Journal Dedicated to Clinical Investigation
News Dec 17, 2010
Clinical Investigation is dedicated to systematic coverage of the methodology, progress and outcomes of clinical trials. As a peer-reviewed, monthly publication Clinical Investigation provides a forum for the rapid publication of original research and critically reviews the latest developments in medical research, from Phase I trials through to post-marketing studies and pharmacoeconomic research.
Clinical Investigation assimilates the wealth of information resulting from the clinical development of new medicines into concise yet comprehensive formats. The journal addresses contemporary issues in clinical drug development and methodology, and also provides a platform for the rapid publication of new drug data from human studies. Coverage spans all therapeutic areas and relates to conventional small-molecule drugs as well as biotech-derived therapeutic entities, including vaccines, monoclonal antibodies, antisense, cell and gene therapies and recombinant proteins. The journal publishes review articles, original papers, perspectives, commentaries, meeting reports, news, views and more.
Clinical Investigation provides a systematic program of peer-reviewed coverage relating to the clinical evaluation of new and established therapies. The audience for Clinical Investigation includes clinical investigators, healthcare decision makers, formulary managers, clinicians, regulatory personnel and medical affairs professionals.
Prof. E. Michael Lewiecki, Senior Editor is responsible for the editorial direction of Clinical Investigation, and supported by a team of Associate Editors and experts making up the international Editorial Advisory board.
Senior Editor Lewiecki commented, “Clinical Investigation is an excellent addition to the Future Science journal collection, Clinical Investigation fulfils an unmet need in providing critical review of objectives and outcomes of clinical trials.”
He stated, “…I have no doubt that Clinical Investigation will become a go-to-source for timely and authoritative discussion regarding clinical research.”
Further information on Clinical Investigation can be found in the Journals section of the Pharma Outsourcing web community.
PPD and Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug DevelopmentNews
Will shorten timelines, reduce costs and simplify contracting process in pediatric programs.READ MORE
Safety and Efficacy of MERS Treatment Confirmed in Phase I TrialNews
An experimental treatment developed from cattle plasma for Middle East respiratory syndrome (MERS) coronavirus infection shows broad potential, according to a small clinical trial. The treatment, SAB-301, was safe and well tolerated by healthy volunteers, with only minor reactions documented.READ MORE